Results for glaxosmithkline sanofi

Add to feed Create your own feed

Latest

Sanofi, GlaxoSmithKline disclose DOJ investigation into Zantac after recalls

Drug giants GlaxoSmithKline and Sanofi Pasteur say they've won a commitment from the US federal government to pay up to $2.1 billion to help the two companies move forward with their proposed joint coronavirus vaccine as part of Operation Warp Speed.

Sanofi and GlaxoSmithKline are in advanced discussions with the European Commission for the supply of up to 300 million doses of a potential Covid-19 vaccine.

Justice Department probes Sanofi and GlaxoSmithKline over possible carcinogen in Zantac pills via @statnews 

Justice Department probes Sanofi and GlaxoSmithKline over possible carcinogen in Zantac pills.. $GSK $SNY #pharma  #Zantac  #cancer  #Medicare  #Medicaid 

$GSK GlaxoSmithKline and Sanofi to supply EU with 300mln COVID-19 vaccine doses via @proactive_UK  #GSK 

Sanofi and GlaxoSmithKline just snagged a $2.1 billion government deal — the biggest yet — for a coronavirus vaccine

On Friday, Pharma giants GlaxoSmithKline and Sanofi Pasteur said they'll supply 100 million doses of an experimental COVID-19 vaccine to the U.S.:

Sanofi and GlaxoSmithKline just snagged a $2.1 billion government deal — the biggest yet — for a coronavirus vaccine

Loading
Loading

Most relevant

BREAKING: The Trump administration will give as much as $2.1 billion to Covid-19 vaccine partners Sanofi and GlaxoSmithKline

tweet picture

The U.S. has inked a $2.1 billion deal with Sanofi and GlaxoSmithKline to secure 100 million doses of coronavirus vaccine when approved

Drug giants GlaxoSmithKline and Sanofi Pasteur say they've won a commitment from the US federal government to pay up to $2.1 billion to help the two companies move forward with their proposed joint coronavirus vaccine as part of Operation Warp Speed.

The U.S. government will pay $2.1 billion to Sanofi and GlaxoSmithKline for a coronavirus vaccine to cover 50 million people $SASY $GSK

Sanofi and GlaxoSmithKline agree to supply the U.K. with up to 60 million doses of their experimental coronavirus vaccine

Britain signs deal for the supply of up to 60 million doses of a potential #coronavirus  vaccine developed by Sanofi and GlaxoSmithKline

GlaxoSmithKline and Sanofi, partners developing a potential coronavirus vaccine, are discussing a $624 million deal to supply the U.K. government with the shot, assuming it’s successful

Sanofi expects to get approval for a potential coronavirus vaccine it is developing with Britain's GlaxoSmithKline by the first half of next year

GlaxoSmithKline, the world’s biggest vaccine maker, and Sanofi, the fourth largest, are joining forces to develop a coronavirus vaccine in a collaboration that—if successful—could pump out hundreds of millions of doses by the second half of 2021

Two of the world's largest vaccine manufacturers — GlaxoSmithKline and Sanofi — are partnering to develop a new vaccine to prevent COVID-19. GSK says it's hoping the partnership will reduce development time considerably.

Loading
Loading